What is the UroLift system?
The UroLift system is a new minimally invasive device designed to treat lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).
How does the UroLift system work?
The UroLift system relieves prostate obstruction and opens the urethra directly by retracting the obstructing prostatic lobes without cutting, heating, or removing prostate tissue. The delivery device transurethrally pushes aside the obstructive prostate lobes like opening window curtains while leaving the prostate intact.
What are the benefits of the UroLift system?
The principle difference is that there is no cutting with UroLift and no removal of prostate tissue. Your consultant will explain about the possible benefits linked to the preservation of sexual function.
Does the UroLift system have NICE guidance?
Yes. In January 2014, the National Institute for Health and Clinical Excellence (NICE) issued an Interventional Procedure Guidance (IPG) approving the UroLift prostatic urethral lift implant for use by UK doctors. Additionally, the UroLift System is CE marked in Europe and FDA cleared in the USA. In the UK, the UroLift system is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men over the age of 50.
Is the treatment permanent?
The UroLift implant is a permanent implant, and the treatment is intended to be permanent. The UroLift system does not preclude UroLift system retreatment or other BPH treatments, should that be desired at some time in the future.
It is important to note that the UroLift is a new procedure with limited long term results available at this time. Bleeding, infection, post operative pain and migration of the implants are all possible risks and complications.